Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Covington
Cantor Fitzgerald
Chubb
Queensland Health
Boehringer Ingelheim
Novartis
Harvard Business School
Healthtrust
Daiichi Sankyo

Generated: August 16, 2017

DrugPatentWatch Database Preview

Loxapine succinate - Generic Drug Details

« Back to Dashboard

What are the generic sources for loxapine succinate and what is the scope of loxapine succinate freedom to operate?

Loxapine succinate
is the generic ingredient in two branded drugs marketed by Watson Labs, Actavis Labs Ut Inc, Mylan, Elite Labs Inc, and Lannett Holdings Inc, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for loxapine succinate. Ten suppliers are listed for this compound.

Summary for Generic Name: loxapine succinate

Tradenames:2
Patents:0
Applicants:5
NDAs:8
Drug Master File Entries: see list8
Suppliers / Packagers: see list10
Bulk Api Vendors: see list41
Clinical Trials: see list198
Patent Applications: see list1,644
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:loxapine succinate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Elite Labs Inc
LOXAPINE SUCCINATE
loxapine succinate
CAPSULE;ORAL076868-003Aug 4, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
LOXAPINE SUCCINATE
loxapine succinate
CAPSULE;ORAL076762-003Nov 1, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Lannett Holdings Inc
LOXAPINE SUCCINATE
loxapine succinate
CAPSULE;ORAL090695-001Sep 26, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
LOXAPINE SUCCINATE
loxapine succinate
CAPSULE;ORAL072205-001Jun 15, 1988ABRXNoNo► Subscribe► Subscribe► Subscribe
Elite Labs Inc
LOXAPINE SUCCINATE
loxapine succinate
CAPSULE;ORAL076868-001Aug 4, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: loxapine succinate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Citi
Chubb
US Army
Fuji
Baxter
Cantor Fitzgerald
Novartis
Teva
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot